WallStreetZenWallStreetZen

NYSE: DHR
Danaher Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Danaher earnings were $4.0B for the trailing 12 months ending Jun 26, 2026, with 19.5% growth year over year. The latest DHR earnings report on Jun 26, 2026 announced Q2 2026 earnings of $870.0M, down 15.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DHR reported annual earnings of $3.6B, with -7.3% growth. The next DHR earnings date is Oct 20, 2026.

DHR past earnings growth

How has DHR's earnings growth performed historically?

Company
19.45%
Industry
9.34%
Market
92%
DHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DHR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DHR earnings history

Current Revenue
$25.1B
Current Earnings
$4.0B
Current Profit Margin
15.9%
DHR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

DHR Return on Equity

Current Company
7.7%
Current Industry
-30.6%
Current Market
33.1%
DHR's Return on Equity (7.7%)... subscribe to Premium to read more.
High Return on Equity Performance

DHR Return on Assets

Current Company
4.7%
Current Industry
5.9%
DHR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DHR announces earnings.

DHR Return on Capital Employed

Current Company
6.01%
Current Industry
12.1%
DHR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DHR vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DHR$7.60B$4.00B-5.86%$5.65
TMO$11.97B$6.97B-3.07%$18.62
NTRA-$158.89M-$192.35MN/A-$1.35
IDXX$1.62B$1.14B+10.96%$14.33
A$1.96B$1.41B+10.68%$5.00
View Top Diagnostic & Research Stocks

DHR earnings dates

Next earnings date
Oct 20, 2026

Danaher Earnings Reports & History FAQ

What were Danaher's earnings last quarter?

On DHR's earnings call on Jul 21, 2026, Danaher (NYSE: DHR) reported Q2 2026 earnings per share (EPS) of $1.23, up 59.74% year over year. Total DHR earnings for the quarter were $870.00 million. In the same quarter last year, Danaher's earnings per share (EPS) was $0.77.

If you're new to stock investing, here's how to buy Danaher stock.

When does Danaher report earnings?

The next DHR earnings call is Oct 20, 2026. Add DHR to your watchlist to be reminded of Danaher's next earnings date.

Is Danaher profitable or losing money?

As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Jun 26, 2026 was $4.00 billion, a 17.32% increase year over year.

What was DHR's earnings growth in the past year?

As of Danaher's earnings date in Jul 21, 2026, Danaher's earnings has grown 19.45% year over year. This is 10.11 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 9.34%. DHR earnings in the past year totalled $4.00 billion.

What are Danaher's earnings expectations?

The current EPS estimate for Danaher's earnings report in Oct 20, 2026 is $1.96.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.